Vir Biotechnology Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Vir Biotechnology Inc.
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Francisco
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
VIR
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001706431
EIN
81-2730369

Board of directors

Follow this board

Chief executives

Backer Marianne De · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of May 25, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

12 of this board's directors also sit on 23 other boards.

Network of Vir Biotechnology Inc.'s board connections Alnylam Pharmaceuticals Inc. Alnylam Pharmaceutical... ADC Therapeutics SA ADC Therapeutics SA Agilent Technologies Inc. Agilent Technologies I... Allogene Therapeutics Inc. Allogene Therapeutics... Arrowhead Pharmaceuticals Inc. Arrowhead Pharmaceutic... Denali Therapeutics Inc. Denali Therapeutics In... Faeth Therapeutics Inc. Faeth Therapeutics Inc... Fate Therapeutics Inc. Fate Therapeutics Inc. Fortinet Inc. Fortinet Inc. Immunocore Holdings plc Immunocore Holdings pl... Kardigan Inc. Kardigan Inc. Lyell Immunopharma Inc. Lyell Immunopharma Inc... Mirum Pharmaceuticals Inc. Mirum Pharmaceuticals... Prime Medicine Inc. Prime Medicine Inc. Rapport Therapeutics Inc. Rapport Therapeutics I... Sana Biotechnology Inc. Sana Biotechnology Inc... Backer Marianne De Backer Marianne De Charles Elliott Sigal Charles Elliott Siga... George A. Scangos George A. Scangos Janet Napolitano Janet Napolitano Phillip A. Sharp Phillip A. Sharp Robert J. Perez Robert J. Perez Robert Nelsen Robert Nelsen Saira Ramasastry Saira Ramasastry Timothy Coughlin Timothy Coughlin Vicki L. Sato Vicki L. Sato Vir Biotechnology Inc.
Shared director Other board Same sector +7 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$21,003,623
52 sales by 10 insiders
Date Insider Transaction Shares Price Value
Aug 11, 2026 Robert J. More Director Other −8,000 — —
Aug 11, 2026 Robert J. More Director Other +8,000 — —
Jun 9, 2026 Timothy Coughlin Director Grant or award +8,000 — —
Jun 9, 2026 Timothy Coughlin Director Grant or award +8,000 — —
Jun 1, 2026 Janet Napolitano Director Open-market sale −3,200 $9.45 $30,240
Jun 1, 2026 Sabatini Brent Officer (SVP, Chief Accounting Officer) Open-market sale −379 $9.45 $3,582
May 27, 2026 Charles Elliott Sigal Director Grant or award +8,000 — —
May 27, 2026 Janet Napolitano Director Grant or award +8,000 — —
May 27, 2026 Robert J. More Director Grant or award +8,000 — —
May 27, 2026 Jeffrey S. Hatfield Director Grant or award +8,000 — —
May 27, 2026 Ramy Farid Director Grant or award +8,000 — —
May 27, 2026 Norbert W. Bischofberger Director Grant or award +8,000 — —
May 1, 2026 Vicki L. Sato Director Open-market sale −22,000 $10.05 $221,100
Apr 29, 2026 Backer Marianne De Director, Officer (President and CEO) Other −233,532 — —
Apr 29, 2026 Backer Marianne De Director, Officer (President and CEO) Other +233,532 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.